Study on the mechanism of hsa_circ_0021205 mediating tumor stem cell differentiation in the occurrence of ovarian endometrioid carcinoma

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100052166

Enrollment

Unknown

Registered

2021-10-20

Start date

2022-04-01

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis-associated ovarian cancer

Interventions

endometriosis group:No

Ovarian cancer and adjacent tissues group:No

Eligibility

Sex/Gender

Female

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with endometriosis, patients diagnosed with ovarian cancer; 2.Voluntary signing of informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe mental illnesses such as pregnant women and lactating women, bipolar disorder, schizophrenia, etc; 2. Other situations considered by the investigator to be inappropriate for participating in the study.

Design outcomes

Primary

Measure	Time frame
hsa_circ_0021205;	—

Countries

China

Contacts

Public ContactWang Yanqiu

Tongji hospital of tongji university

wangfan2002@126.com+86 13585809660

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026